Skip to content
Home » BA.2.86


JN.1 COVID variant

JN.1 variant of COVID update

The JN.1 COVID-19 variant, a subvariant of Omicron, is rapidly spreading in the USA. While it may evade immunity from vaccines or previous infection, current vaccines appear effective against it. It poses a greater risk to the unvaccinated. Public health agencies are closely monitoring its transmission and severity to prevent potential disasters. COVID-19 remains a significant threat.

BA.2.86 variant

New information on the BA.2.86 COVID variant

The BA.2.86 variant of the SARS-CoV-2 virus, also called the Pirola variant, is back on the CDC’s radar despite not causing significant infection increases previously. It may evade vaccines or natural immunity and is currently accounting for 9% of cases but isn’t driving infection or hospitalization increases. The public health risk is considered low compared to other variants. Vaccinated individuals have reduced risk of hospitalization, and there is no evidence the strain can evade vaccine or natural immunity entirely. Updates will continue as the situation develops.